Chicago, IL, United States of America

Dan L Nicolae

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Michigan. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dan L Nicolae. Retrieved from https://idiyas.com/inventor/dan-l-nicolae

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dan L. Nicolae and His Work on Nod2

Introduction

Dan L. Nicolae is an inventor associated with Chicago, Illinois. His work includes research on Nod2, an intracellular signaling protein connected to immune responses and Crohn’s disease. The supplied information lists 1 patent associated with him.

Latest Patents

The listed patent, “Nod2 Nucleic Acids and Proteins,” concerns the Nod2 protein and the nucleic acids that encode it. The invention describes isolated nucleotide sequences and Nod2 peptides, antibodies that bind specifically to Nod2, and methods for detecting Nod2 or screening compounds that may alter Nod2-related signal transduction. It also addresses Nod2 variant alleles and methods for identifying individuals at increased risk of developing Crohn’s disease.

Career Highlights

Nicolae’s listed institutional affiliations include the University of Michigan and the University of Chicago. The supplied information does not specify his roles or dates of work at either institution.

Collaborations

The listed collaborators include Yasunori Ogura and Naohiro Inohara. Their connection to Nicolae’s work is reflected in the supplied information about the Nod2 invention.

Conclusion

Dan L. Nicolae’s listed patent focuses on Nod2 biology and potential approaches to studying immune signaling and Crohn’s disease risk.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…